Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI — Stella

Home/Coronary Artery Disease/Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

View on ClinicalTrials.gov

Recruiting

Back to Coronary Artery Disease trials

Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(3 sites)

Poland

National Institute of Cardiology, Warsaw, Warsaw

1st Military Clinical Hospital, Lublin

Hospital of the Ministry of the Interior and Administration, Lublin

Key details

Sponsor

National Institute of Cardiology, Warsaw, Poland

Collaborators

Medical Research Agency, Poland

Enrollment target

~74 participants

Started

July 2025

Primary completion

March 2028

Age range

18 Years and older

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.